Irreversible Electroporation and Beta-Glucan-Induced Trained Innate Immunity for Treatment of Pancreatic Ductal Adenocarcinoma: A Phase II Study

医学 不可逆电穿孔 胃肠病学 免疫疗法 内科学 临床研究阶段 临床试验 电穿孔 癌症 外科 生物化学 基因 化学
作者
Robert C.G. Martin,Yan Li,Emily A. Shore,Danial A. Malik,Hong Li,Xiao Hu,Traci Hayat,Min Tan,Kelly M. McMasters,Jun Yan
出处
期刊:Journal of The American College of Surgeons [Lippincott Williams & Wilkins]
卷期号:240 (4): 351-361 被引量:2
标识
DOI:10.1097/xcs.0000000000001291
摘要

BACKGROUND: Irreversible electroporation (IRE) has augmented the effects of certain immunotherapies in pancreatic ductal adenocarcinoma (PDA). Yeast-derived particulate beta-glucan induces trained innate immunity and successfully reduced murine pancreatic cancer burden. This is a phase II study to test the hypothesis that IRE may augment beta-glucan-induced trained immunity in patients with PDA. STUDY DESIGN: In this phase II clinical trial (NCT03080974), surgical ablative IRE was performed on clinical stage III PDA followed by oral beta-glucan administration for 12 months or until disease recurrence. Peripheral blood was taken preoperative, 14 days, and every 3 months and was evaluated by mass cytometry and compared with patients who received IRE alone. RESULTS: Thirty consecutive patients with preoperative clinical stage III PDA were treated with IRE and then initiated on oral beta-glucan postoperatively were compared with 20 patients treated with IRE alone. There were no dose-limiting toxicities with oral beta-glucan, and compliance with therapy was 96% in all patients. Seven patients (23%) developed grade 3 or 4 treatment-related adverse events at 90 days; none required a dose modification of oral beta-glucan. A median disease-free interval (DFI) was 18 months (range 6 to 48 months), with a median overall survival (OS) of 32.5 months (range 4 to 53 months). At 12 months post-IRE, immunophenotyping was demonstrated a significant effect with improvement in the IRE-beta-glucan-treated group. This also resulted in a significant decrease on naive CD4 and CD8 T cells with increased CD4 and CD8 terminal effector cells in the IRE-beta-glucan-treated group, which correlated with a significant improvement in DFI and OS (p = 0.001). CONCLUSIONS: Combined beta-glucan with IRE-ablated PDA tumor cells elicited a potent trained response and augmented antitumor functionality at 12 months post-IRE, which translated into an improved DFI and OS.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
来来完成签到,获得积分10
6秒前
09nankai应助科研通管家采纳,获得50
6秒前
研友_VZG7GZ应助科研通管家采纳,获得10
6秒前
曾经以亦完成签到,获得积分10
8秒前
机智冬菱完成签到 ,获得积分10
9秒前
牛仔完成签到 ,获得积分10
9秒前
9秒前
HY完成签到 ,获得积分10
10秒前
11秒前
胖胖完成签到 ,获得积分0
13秒前
小陈完成签到 ,获得积分10
13秒前
xin完成签到,获得积分10
13秒前
15秒前
drjyang完成签到,获得积分10
16秒前
JIA应助Sally采纳,获得10
17秒前
17秒前
淡如水完成签到 ,获得积分10
17秒前
顾城浪子发布了新的文献求助70
17秒前
Jasper应助细心的语蓉采纳,获得10
19秒前
风信子deon01完成签到,获得积分10
22秒前
科研通AI6.2应助Marksman497采纳,获得10
23秒前
说如果完成签到 ,获得积分10
23秒前
英吉利25发布了新的文献求助10
25秒前
26秒前
环游世界完成签到 ,获得积分10
28秒前
cheng完成签到 ,获得积分10
28秒前
29秒前
会撒娇的乌冬面完成签到 ,获得积分10
30秒前
科目三应助Wang采纳,获得10
30秒前
嘟嘟完成签到 ,获得积分10
31秒前
神外王001完成签到 ,获得积分10
32秒前
33秒前
搞怪的白云完成签到 ,获得积分0
33秒前
Lachs完成签到 ,获得积分10
33秒前
33秒前
文文武完成签到,获得积分10
34秒前
绿袖子完成签到,获得积分10
36秒前
panda完成签到,获得积分0
37秒前
38秒前
ABJ完成签到 ,获得积分10
38秒前
高分求助中
Modern Epidemiology, Fourth Edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Propeller Design 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
First commercial application of ELCRES™ HTV150A film in Nichicon capacitors for AC-DC inverters: SABIC at PCIM Europe 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6004972
求助须知:如何正确求助?哪些是违规求助? 7525918
关于积分的说明 16112121
捐赠科研通 5150408
什么是DOI,文献DOI怎么找? 2759754
邀请新用户注册赠送积分活动 1736771
关于科研通互助平台的介绍 1632084